- Report
- September 2021
- 171 Pages
Global
From €3164EUR$3,185USD£2,631GBP
€4520EUR$4,550USD£3,758GBP
- Report
- July 2021
- 151 Pages
Europe
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
- Report
- July 2021
- 148 Pages
Middle East, Africa
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
- Report
- August 2018
- 154 Pages
Global
From €3164EUR$3,185USD£2,631GBP
€4520EUR$4,550USD£3,758GBP
- Report
- November 2023
- 140 Pages
Global
From €2979EUR$2,999USD£2,477GBP
- Report
- July 2023
- 160 Pages
Global
From €5960EUR$5,999USD£4,955GBP
- Report
- July 2023
- 160 Pages
Global
From €5960EUR$5,999USD£4,955GBP
- Report
- July 2023
- 160 Pages
Global
From €5960EUR$5,999USD£4,955GBP
- Report
- June 2023
- 140 Pages
Global
From €5960EUR$5,999USD£4,955GBP
- Report
- May 2023
- 140 Pages
Global
From €5960EUR$5,999USD£4,955GBP
- Report
- May 2023
- 147 Pages
Global
From €5960EUR$5,999USD£4,955GBP
- Report
- May 2023
- 140 Pages
Global
From €5960EUR$5,999USD£4,955GBP
- Report
- May 2023
- 147 Pages
Global
From €5960EUR$5,999USD£4,955GBP
- Report
- April 2023
- 147 Pages
Global
From €5960EUR$5,999USD£4,955GBP
- Report
- August 2023
- 145 Pages
Global
From €3129EUR$3,150USD£2,602GBP
- Report
- August 2023
- 145 Pages
Global
From €3129EUR$3,150USD£2,602GBP
- Report
- May 2023
- 119 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- June 2023
- 1026 Pages
Europe
From €8936EUR$8,995USD£7,430GBP
- Report
- March 2023
- 666 Pages
United States
From €7943EUR$7,995USD£6,604GBP
- Report
- December 2022
- 56 Pages
Global
From €4962EUR$4,995USD£4,126GBP
The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more